EnVVeno Medical Corporation (NASDAQ:NVNO)

PRESS RELEASE

published on 04/16/2024 at 15:00, 1 year 10 months ago

New Topline Efficacy Data from the enVVeno Medical VenoValve(R) Pivotal Trial to be Presented at the 46th Annual Charing Cross Symposium on April 24, 2024
enVVeno Medical Corporation to present additional topline efficacy data from VenoValve U.S. pivotal trial at 2024 Charing Cross International Symposium in London. Data to review clinical status of severe Chronic Venous Insufficiency patients post VenoValve implantation

VenoValve Chronic Venous Insufficiency EnVVeno Medical Corporation SAVVE Trial Charing Cross International Symposium
BRIEF

published on 04/09/2024 at 14:50, 1 year 10 months ago

EnVVeno Medical Appoints Andrew Cormack as Chief Commercial Officer to Spearhead VenoValve® Commercialization

EnVVeno Medical VenoValve® Chronic Venous Insufficiency (CVI) SAVVE U.S. Pivotal Study Commercialization Strategy
BRIEF

published on 04/09/2024 at 14:50, 1 year 10 months ago

EnVVeno Medical nomme Andrew Cormack au poste de directeur commercial pour diriger la commercialisation de VenoValve®

EnVVeno Medical VenoValve® Insuffisance Veineuse Chronique (IVC) Étude Pivot Américaine SAVVE Stratégie De Commercialisation
PRESS RELEASE

published on 04/09/2024 at 14:45, 1 year 10 months ago

enVVeno Medical Appoints Andrew Cormack as Its Chief Commercial Officer
enVVeno Medical Corporation appoints Andrew Cormack as Chief Commercial Officer to drive VenoValve's commercialization strategy. PMA application for FDA approval on track for Q4 2024

FDA Approval VenoValve EnVVeno Medical Corporation Commercialization Strategy Andrew Cormack
BRIEF

published on 03/15/2024 at 14:05, 1 year 11 months ago

EnVVeno Medical to Showcase Its Innovations in an Upcoming Virtual Investor Event

EnVVeno Medical Medical Innovation Virtual Investor Event Venous Disease Treatment Corporate Overview
BRIEF

published on 03/15/2024 at 14:05, 1 year 11 months ago

EnVVeno Medical présentera ses innovations lors d'un prochain événement virtuel pour les investisseurs

Innovation Médicale EnVVeno Medical Événement Virtuel Pour Les Investisseurs Traitement Des Maladies Veineuses Vue D'ensemble De L'entreprise
PRESS RELEASE

published on 03/15/2024 at 14:00, 1 year 11 months ago

enVVeno Medical to Participate in the Virtual Investor Lunch Break: The enVVeno Opportunity
enVVeno Medical to present at Virtual Investor Lunch Break on March 21, 2024, with CEO Robert Berman discussing the company's outlook and the enVVeno Opportunity

EnVVeno Medical Venous Disease Treatment Virtual Investor Lunch Break Robert Berman Bioprosthetic Solutions
BRIEF

published on 03/06/2024 at 14:45, 1 year 11 months ago

EnVVeno Medical Corporation Announces Positive Results from VenoValve Pivotal Trial

FDA Approval EnVVeno Medical VenoValve Chronic Venous Insufficiency Clinical Improvement
BRIEF

published on 03/06/2024 at 14:45, 1 year 11 months ago

EnVVeno Medical Corporation annonce les résultats positifs de l'essai pivot VenoValve

EnVVeno Medical Insuffisance Veineuse Chronique VenoValve Approbation De La FDA Amélioration Clinique
PRESS RELEASE

published on 03/06/2024 at 14:40, 1 year 11 months ago

Positive Topline Efficacy Data Showing Significant Clinical Improvement from enVVeno Medical’s VenoValve(R) Pivotal Trial to be Presented Today at the VENOUS2024 American Venous Forum Annual Meeting
enVVeno Medical presents positive topline efficacy data from the SAVVE U.S. pivotal trial for the VenoValve at the 2024 American Venous Forum Annual Meeting, showing significant clinical improvement in CVI patients

EnVVeno Medical VenoValve Clinical Improvement SAVVE Trial CVI Patients

Published on 02/18/2026 at 15:00, 11 minutes ago

Jaguar Health Announces a Special One-time Stock Dividend
Published on 02/18/2026 at 14:25, 46 minutes ago

Mako Mining Announces Amended and Restated Definitive Agreements for Restructure of Mt. Hamilton Acquisition Consideration and Filing of Supplement to Management Information Circular
Published on 02/18/2026 at 14:00, 1 hour 11 minutes ago

Revolve Achieves Key Interconnection Milestone On 130 MW "El 24 Wind Project" In Mexico
Published on 02/18/2026 at 14:00, 1 hour 11 minutes ago

Datametrex Receives $1M Order from Fortune 500 Client
Published on 02/18/2026 at 14:00, 1 hour 11 minutes ago

Troubadour Resources Announces Non-Brokered Private Placement

View all ACCESSWIRE

Published on 02/18/2026 at 15:00, 11 minutes ago

LHV Bank updates Results Review report for Eleving Group
Published on 02/18/2026 at 14:55, 16 minutes ago

Tata Communications Unveils Bold, New Corporate Brand Identity: 'Together, limitless'
Published on 02/18/2026 at 14:40, 31 minutes ago

Mecademic Secures Strategic Funding to Drive Global Expansion
Published on 02/18/2026 at 14:30, 41 minutes ago

BOC Group Introduces ADONIS 18.0: Advancing Intelligent Process Management
Published on 02/18/2026 at 14:07, 1 hour 3 minutes ago

Original-Research: ad pepper media International N.V. (von First Berlin Equity Research GmbH): Buy

View all EQS

Published on 02/18/2026 at 13:45, 1 hour 25 minutes ago

NRJ GROUP - Non renouvellement Licence FM Nationale NRJ Suède
Published on 02/18/2026 at 11:00, 4 hours 10 minutes ago

Mise à disposition des documents préparatoires à l'AG
Published on 02/18/2026 at 08:07, 7 hours 4 minutes ago

TERACT - Changes to Financial calendar
Published on 02/18/2026 at 08:07, 7 hours 4 minutes ago

TERACT - Modification du calendrier financier
Published on 02/18/2026 at 07:30, 7 hours 41 minutes ago

PR Carrefour - Vusion

View all LES ECHOS COMFI WIRE

News